Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Technology Industry News Can Complii FinTech (ASX: CF1) turn ARR stability into profits? Complii FinTech Solutions Limited’s H1 FY26 results show whether its rebuilt platform and cost reset can finally unlock SaaS operating leverage. Read the full analysis. byVenkateshMarch 1, 2026